Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mesenteric microcirculation consists of small arteries (arterioles), capillaries, and venules within the mesentery that supply the gastrointestinal tract[1][3]. This network facilitates the exchange of gases, nutrients, waste, and immune cells between blood and intestinal tissue and is integral to maintaining intestinal and systemic homeostasis. Dysfunction of the mesenteric microcirculation, often through inflammation, ischemia, or sepsis, leads to compromised blood flow and oxygen delivery, increased leukocyte adhesion/rolling, breakdown of the endothelial barrier, and can contribute to multi-organ dysfunction or failure[1][6]. While specific molecules within this network (such as adhesion molecules or endothelial receptors) may be drug targets, "mesenteric microcirculation" as a whole is a physiological structure, not a druggable target by itself[1][3][6].
Improvement of microvascular perfusion (e.g., via inhibition of leukocyte adhesion, improvement of endothelial function, vasodilation)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mesenteric microcirculation.